Market Place
Sourcing Support
Hospira`s Generic Epoetin Alfa Receives Supplemental Approval in US
30 Jun 2020 //
FDA
Amgen Inc. v. Hospira, Inc. (Fed. Cir. 2019)
19 Dec 2019 //
PATENTDOCS
Federal Circuit Affirms Amgen’s $70 Million Damages Award Against Pfizer Unit
17 Dec 2019 //
BIGMOLECULEWATCH
The top 10 franchise drugs in biopharma history will earn $1.4T (trillion)
16 Aug 2019 //
ENDPTS
FibroGen sinks as roxadustat safety results confuse investors
11 May 2019 //
FIERCE BIOTECH
AZ preps new roxadustat filings, though data foxes investors
11 May 2019 //
PMLIVE
Hospira`s Retacrit (Epoetin Alfa-Epbx) Receives Approval in US
23 Jan 2019 //
FDA
Pfizer launches biosimilar version of Amgen`s Epogen
15 Nov 2018 //
BIOPHARMA DIVE
Sandoz`s Binocrit (epoetin alfa) Receives Approval in Europe
05 Oct 2018 //
EMA
Medice AP`s Abseamed (epoetin alfa) Receives Approval in Europe
04 Oct 2018 //
EMA
Hexal AG`s Epoetin Alfa Hexal Receives Approval in Europe
02 Oct 2018 //
EMA
Pfizer`s Retacrit, the First ESA to be FDA Approved
31 Jul 2018 //
BIOSPACE
Amgen’s Epogen, Procrit (Epoetin Alfa ) Receives Supplemental Approval In US
26 Jul 2018 //
FDA
Mylan biosim ready to challenge Amgen blockbuster Neulasta
06 Jun 2018 //
FIERCE PHARMA
Epogen® Litigation Status in Face of Retacrit Regulatory Approval
22 May 2018 //
BIOSIMILAR
Pfizer`s biosimilar of Amgen, J&J`s anemia treatments gets FDA nod
17 May 2018 //
REUTERS
Pfizer finally finishes a 3y regulatory odyssey, bagging FDA OK Epogen knockoff
16 May 2018 //
ENDPTS
Pfizer’s Epoetin Alfa Biosimilar Approved by FDA
15 May 2018 //
RAPS
Kirin Cashes Out of Amgen Drug Joint Venture for $780M
31 Oct 2017 //
BIOSPACE
Enforcement Report - Week of September 27, 2017
28 Sep 2017 //
FDA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.